"Humanized Mouse model in biomedical science”

Slides:



Advertisements
Similar presentations
Lecture 10 Thymocyte selection II
Advertisements

CHIMERISM & DLI Dr. Serdar ŞIVGIN Kayseri Feb, 2011.
Prolonged Diabetes Reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates Hering et al, Nature.
Doug Brutlag 2011 Genomics, Bioinformatics & Medicine Doug Brutlag Professor Emeritus of.
Allogeneic Stem Cell Transplantation: The Journey
Introduction to Haematopoietic Stem Cell Transplantation (HSCT) Covenant Health System HSCT Program Lubbock, Texas April 4, 2007.
Responses to alloantigens and transplant rejection
Towards a small animal model for hepatitis C Alexander Ploss & Charles M. Rice EMBO reports (2009) 10, Abteilung und/oder Titel Datum.
Cord Blood-Derived Regulatory T Cells: A Novel Cure for Graft-Versus-Host-Disease Siddharth Damania 2007.
Shen Bin Journal Club. What is MSCs?  Mesenchymal stem cells (MSCs) are multipotent stromal cells that can differentiate into a variety of.
Lecture 12. Stem Cells, Nuclear Transplantation, and Combined Cell & Gene Therapy Strategies.
Tolerance Induction Dr. S. Strober Stanford University.
Animal Models in Immunology Adam Brown and Teresa Fulk.
Bone marrow Transplant in Paediatric Haematology
Basic Immunology of the Mouse (and Human) Nicholas P. Restifo, MD October 19, 2015.
Transplantation of Tissues and Organs
Transplantation Prof. Zahid Shakoor College of Medicine King Saud University.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Natural Killer Cells:
NIDA Center Genomics Projects Kathie Walters October 2008.
Elements of the Immune System and their Roles in Defense
Relationship between Mixed Chimerism and Clinical Tolerance after Combined Kidney and Hematopoietic Cell Transplantation using Total Lymphoid Irradiation.
Transplantation Immunology Unit College of Medicine
Per microtrasplantation
Transplantation David Straus, Ph.D. Objectives
Transplantation Immunology Unit College of Medicine
Immune Tolerance Kyeong Cheon Jung Department of Pathology
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Depletion of Naïve Lymphocytes with Fas Ligand Ex Vivo Prevents Graft-versus-Host Disease without Impairing T Cell Support of Engraftment or Graft-versus-Tumor.
A New Strategy for Treatment of Autoimmune Diseases in Chimeric Resistant MRL/lpr Mice by Kenji Takeuchi, Muneo Inaba, Shigeo Miyashima, Ryokei Ogawa,
Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte.
Transplantation Immunology
Molecular Therapy - Methods & Clinical Development
by Prabal Banerjee, Adam Tripp, Michael D
Figure 1 Outline of the AHSCT procedure
Isabel Barao, William J Murphy 
Results of Phase 1 Trial of Treg Adoptive Cell Transfer in Living Donor Kidney Transplant Recipients TRACT Therapeutics™
PreImplantation Factor Reduces Graft-versus-Host Disease by Regulating Immune Response and Lowering Oxidative Stress (Murine Model)  Yehudith Azar, Reut.
Transplantation Rejection of foreign tissue grafts is due to immune responses to alloantigens on the graft Blood group antigens Polymorphic MHC antigens.
Experimental Hematology
Giandor Saltz Gigley Molecuar Biology Lab INBRE Spring 2016
Viral load and CD4+ T cells in CD8+ T cell–depleted YU-2–infected MISTRG mice. Viral load and CD4+ T cells in CD8+ T cell–depleted YU-2–infected MISTRG.
Jamie Naden, PhD Scientist Veterinary Science, Research and Support
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
T Cell and B Cell Immunity can be Reconstituted with Mismatched Hematopoietic Stem Cell Transplantation Without Alkylator Therapy in Artemis-Deficient.
Hematopoiesis: A Human Perspective
A Radio-Resistant Perforin-Expressing Lymphoid Population Controls Allogeneic T Cell Engraftment, Activation, and Onset of Graft-versus-Host Disease in.
HSC extrinsic sex-related and intrinsic autoimmune disease–related human B-cell variation is recapitulated in humanized mice by Chiara Borsotti, Nichole.
Transplantation Immunology
In Situ Activation and Expansion of Host Tregs: A New Approach to Enhance Donor Chimerism and Stable Engraftment in Major Histocompatibility Complex-Matched.
Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines by Yanyan Zhang, Liang He, Dorothée.
David Traver, Koichi Akashi, Irving L. Weissman, Eric Lagasse  Immunity 
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Persistence of host dendritic cells after transplantation is associated with graft-versus- host disease  Geoffrey W. Chan, Gullu Gorgun, Kenneth B. Miller,
Umbilical Cord Blood Xenografts in Immunodeficient Mice Reveal That T Cells Enhance Hematopoietic Engraftment Beyond Overcoming Immune Barriers by Stimulating.
Volume 11, Issue 2, Pages (August 2018)
Cytokines and cytotoxic pathways in engraftment resistance to purified allogeneic hematopoietic stem cells  Christian Scheffold, Yolanda C. Scheffold,
Fig. 1 HSCT: A platform for cellular therapies.
Brile Chung, Eric Dudl, Akira Toyama, Lora Barsky, Kenneth I. Weinberg 
Is KIR- typing relevant to HCT donor selection?
Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation:
The incidence and risk factors of invasive fungal infection after haploidentical haematopoietic stem cell transplantation without in vitro T-cell depletion 
Volume 21, Issue 5, Pages (May 2013)
Human hematopoietic stem cell maintenance and myeloid cell development in next-generation humanized mouse models by Trisha R. Sippel, Stefan Radtke, Tayla.
Volume 25, Issue 11, Pages (November 2017)
Volume 8, Issue 6, Pages (June 2017)
Analysis of peripheral blood CD4+CD25+ T-cells after B6
Induction of MHC-mismatched mixed chimerism via anti-CD3/CD8–based conditioning corrects B-cell autoimmunity in NOD mice. Induction of MHC-mismatched mixed.
Anti-PD-1H Antibody Prevents Graft Versus Host Disease
Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies by Christian Chabannon, Jurgen Kuball, Attilio Bondanza, Francesco.
Presentation transcript:

"Humanized Mouse model in biomedical science” Paresh Vishwasrao

HSCs Transplantation : Chimeric Reconstitution

Introduction of Humanized Mouse Model What, how, when and why ? Creating Humanized Mice : Timeline Development and Functional Aspect. Limitations and Improvisation. Applications of Humanized Mouse Model Patient Derived Xenograft (PDX) : mouse model.

Humanized Mouse Model : hu-Mice What, how, when and why ?

“Hu-Mice”: Mice with human HSCs Pre-Clinical Models Cancer Infections Transplantations Pharm/Tox Stem cells, NIH (2001)

Hematopoietic Stem cells Sources for Hu-Mice

Translating lessons from clinics Source and selection of the stem cells (No T cells) Matching of the human histocompatibility complex Depletion of the “original” hematopoietic system Period of immune deficiency (6-12 months) Graft versus host disease

https://www.youtube.com/watch?v=lHo2hEKCvSA The Jackson Laboratory

Factors determining Human Immune Responses Age of the recipient Strain background and transgenic factors Source of stem cells and human tissues Cell dose and percentage of sub populations Route of administration Sub-lethal radiation dose Surgical procedure and safe housing Brehm et al Clin. Immunol (2010) Vishwasrao.P and Sykes M, ASH (2014)

Mouse Models and Companies

Creating Humanized Mice : Timeline Humanized Mouse Model Creating Humanized Mice : Timeline

Creating Humanized Mice : Timeline

NSG/NRG transplanted with CB stem cells or HSCs

Major Mouse Strains from different Labs

Human Immune System Models

Development and Functional Aspect. Humanized Mouse Model : hu-Mice Development and Functional Aspect.

Engraftment of human Immune System Develops robust Immune system of multiple linages. High T cell and low B cell development. T cell education through autologous thymic tissue. Detectative viral infections (EBV and HIV). Rejection of Pig islets. Nichole Wash, L Shultz. Nat Rev Imm (2017)

Thymus development in BLT mice at 16 Wks post-implant Michael Brehm and Shultz. Nat Med (2008)

Peripheral T cell Development

The NSG™ Mouse

T cell development at 15 wks (Females vs Male)

T cell in PBL< Spleen, LN at 20Wks(Females vs Male)

Limitations and Improvisation Humanized Mouse Model : hu-Mice Limitations and Improvisation

Limitations of huNSG/huNRG Mice

Cytokine Expressed transgenically in NSG mouse

Making of Humanized Mouse Model: “Hu-Mice” i.v/i.p/s.c/i.t Vishwasrao.P and Sykes.M. Am J Transplant (2017)

NSG-SGM3: Stem cell factor, GM-CSF and IL3 New Born , Fetal liver CD34+ and intrahepatically Billerbreck, Ploss et al, Blood (2011)

MISTRG: M-CSF, IL3, SIRPa, THPO and GM-CSF New Born , Fetal liver CD34+ and intrahepatically Rongvaux, Manz, Flavellet al, Nat Biot (2014)

Applications of Humanized Mouse Model Humanized Mouse Model : hu-Mice Applications of Humanized Mouse Model

Application of “Hu-Mice” Infectious disease: Typhoid Fever/Salmonella, Mycobacterium, Malaria, Sepsis Regenerative Medicine: Stem cell transplant Immunity and Autoimmunity: Type 1 Diabetes, Allergic inflammation Transplantation: Xenotransplantation Human Hematopoiesis: Immunobiology, GVHD Cancer Biology: PDX, NK cell therapy, T cell editing

Patient Derived Xenograft (PDX) : mouse model. Humanized Mouse Model Patient Derived Xenograft (PDX) : mouse model.

The Tumor Xenograft Project : AntiCancer PDOX Pre-Clinical https://www.youtube.com/watch?v=DWYkC3CEVB8

Patient Derived Xenograft (PDX) : mouse model

Application of Hu-Mice: Cancer Biologys

Summary

Acknowledgement PhD Lab-Sykes lab Prof. Megan Sykes Previous- PhD lab Dr. HaoWei Li Previous- PhD lab Prof. Christian Buske PhD lab Dr. C.W .Choi Postdoc lab- Davila lab Prof. Marco Davila Dr. Gongobo Collaborator Prof. Marcel Maus Prof. David Weinstock

Schematics : of Immunodeficient mouse models Leonard Shultz. Nat Rev Imm (2007)

Development pathway of Hu-Mice

Innate and Adaptive Immune System